Abbott's Gallant ICD and CRT-D Device Receives CE Mark in the EU
Shots:
- Gallant implantable cardioverter-defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) devices offer patients engagement and remote monitoring via smartphone to patients with abnormal heart rhythms & HF
- The Gallant system pairs with Abbott's secure myMerlinPulse mobile app to improve the connectivity b/w the doctors & patients. The app allows the physician to monitor patients remotely- identification of asymptomatic episodes as well as patient-triggered transmissions- leading to earlier intervention and reduction in clinical burden
- The Gallant CRT-D system includes Abbott's MultiPoint Pacing and SyncAV features to aid patients to respond to CRT therapy while the ICD device includes Abbott's TailoredTherapy suite to help physicians more instinctively program their patient's devices
Click here to read full press release/ article |
Ref: Abbott | Image:Abbott
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com